Glial mitogenic factors, their preparation and use

Details Glial mitogenic factors, their preparation and use Glial mitogenic factors, their preparation and use

2006-11-14

2006-11-14

Andres, Janet L. (Department: 1649)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600

Reexamination Certificate

active

07135456

ABSTRACT:
Disclosed is the characterization and purification of DNA encoding a numerous polypeptides useful for the stimulation of glial cell (particularly, Schwann cell) mitogenesis and treating glial cell tumors. Also disclosed are DNA sequences encoding novel polypeptides which may have use in stimulating glial cell mitogenesis and treating glial cell tumors. Methods for the synthesis, purification and testing of both known and novel polypeptides for their use as both therapeutic and diagnostic aids in the treatment of diseases involving glial cells are also provided. Methods are also provided for the use of these polypeptides for the preparation of antibody probes useful for both diagnostic and therapeutic use in diseases involving glial cells. The present invention is specifically directed to methods of using said polypeptides to induce myelination and to treat multiple sclerosis.

REFERENCES:
patent: 4935341 (1990-06-01), Barbmann et al.
patent: 4968603 (1990-11-01), Slamon et al.
patent: 5237056 (1993-08-01), Fischbach
patent: 5367060 (1994-11-01), Vandlen et al.
patent: 6635249 (2003-10-01), Marchionni et al.
patent: WO8906692 (1989-01-01), None
patent: WO9014357 (1990-01-01), None
patent: WO9115230 (1991-01-01), None
patent: WO9118921 (1991-01-01), None
patent: WO9212174 (1992-01-01), None
Lemke et al.,J. Neurosci, vol. 4, pp. 75-83, 1984.
Peles et al., “Isolation of the Neu/HER-2 Stimulatory Ligand: A 44 Kd Glyco-protein That Induces Differentiation of Mammary Tumor Cells”, Cell 69: 205 (Apr. 1992).
Lupu et al., “Direct Intera-tion of a Ligand for the erbB2 Oncogene Product with the EGF Receptor and p185erbB2”, Science 249: 1552 (Sep. 1990).
Yarcen et al., “Biochemical Analysis of the Ligand for the neu Oncogenic Receptor”, Biochemistry 30: 3543 (1991).
Dobashi et al., “Characterization of a neu/c-erbB-2 protein-specific activating factor”, P.N.A.S., U.S.A. 88: 8582 (Oct. 1991).
Tarakhovsky et al., “A 25 kDa polypeptide in the ligand for p185neu and is secreted by activated macrophages”, Oncogene 6: 2187 (1991).
Davis et al., “Isolation and characterization of a neu protein-specific activating factor from human ATL-2 cell conditioned medium”, Biochem. Biophys. Research Communications 179: 1536 (Sep. 1991).
Huang et al., “Purification and Characterization of the neu/erb B2 Ligand-Growth Factor from Bovine Kidney”, J. Biol. Chem. 257: 11508 (Jun. 1992).
Lupu et al., “Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses”, P.N.A.S., U.S.A. 89: 2287 (Mar. 1992).
Holmes et al., “Identification or Heregulin, a Specific Activator of p185erbB2”, Science 256: 1205 (May 1992).
Wen et al., “Neu Differentiation Factor: A Transmembrane Glycoprotein Containing an EGF Domain and an Immunoglobulin Homology Unit”, Cell 69: 559 (May 1992).
Yarden, “Growth Factor Receptor Tyrosine Kinases”, Ann. Rev. Biochem. 57: 443-478 (1988).
Benveniste, E.N. et al., P.N.A.S., “Purification and characterization of a human T-lymphocyte-derived glial growth promoting factor”, 82: 3930-3934, Jun. 1985.
Kimura, H. et al., “Nature, Structure, expression and function of a Schwannoma derived growth factor”, 348: 257-260, Nov. 15, 1990.
Falls et al., Cell, ARIA, a Potein the stimulates acetypoholine receptor synthesis, is member of the Neu Ligand family, 72: 801-815 (1993).
Brookes et al., “Purification and Preliminary Characterization of a Glial Growth Factor from the Bovine Pituitary”, J. Biol. Chem. 255: 18, 8374-8377 (Sep. 1980).
Brookes et al., “The neuron as a source or mitogen: its influence on the proliferation of glial and non-neural cells”, Garrod and Feldman eds, pp. 309-327 (1980).
Lemke et al. “An Immunochemical Approach to the Purification and Characterization of Glial Growth Factor”, Monoclonal Antibodies to Neural Antigens, McKay, Raff and Reichardt, eds. pp. 133-140 (1981).
Lemke et al., “Identification and Purification of Glial Growth Factor1”, J. Neuroscience, vol. 4, No. 1, pp. 75-83 (Jan. 1984).
Brockes, “Assay and Isolation of Glial Growth Factor from the Bovine Pituitary”, Methods in Enzymology, 147: 217-225 (1987).
Davis et al., “Platelet-derived Growth Factors and Fibroblasts Growth Factors Are Mitogens for Rat Schwann Cells”, J. Cell Biology 110: 1353 (Apr. 1990).
World Patents Index, week 7123, AN=71-400056S, Derwent Publications, Abstract, Teikoku Hormone Manuf. Ltd (1971).

Affiliated with

Also associated with

Rating

Glial mitogenic factors, their preparation and use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glial mitogenic factors, their preparation and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glial mitogenic factors, their preparation and use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3704649